Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CrystalsFirst has pioneered a structure-first approach to accelerate small molecule and fragment-based lead generation against difficult or previously undruggable protein targets. Its MAGNET platform combines advanced crystallography with AI-driven molecular design, supporting over forty partner programs globally. The company’s technologies have been recognized by Fierce Biotech as industry-leading in the CRO space. No direct clinical results are reported since it operates primarily as a service/platform provider rather than developing its own therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CrystalsFirst.